Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiying Pan

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Biometrics|January 13, 2006
Goodness-of-fit methods for generalized linear mixed modelsZhiying Pan, D Y Lin
Journal of Glaucoma|May 24, 2011
Longitudinal changes in anterior chamber configuration in eyes with open-angle glaucoma and associated factorsZhiying Pan, Toshie Furuya, Kenji Kashiwagi
Journal of Biopharmaceutical Statistics|June 9, 2022
A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical dataWen Zhang, Zhiying Pan, Ying Yuan
Contemporary Clinical Trials|September 10, 2021
Elastic meta-analytic-predictive prior for dynamically borrowing information from historical data with application to biosimilar clinical trialsWen Zhang, Zhiying Pan, Ying Yuan
Current Eye Research|February 17, 2012
Role of retinal glial cell glutamate transporters in retinal ganglion cell survival following stimulation of NMDA receptorToshie Furuya, Zhiying Pan, Kenji Kashiwagi
Biometrics|November 15, 2019
Design and analysis of bridging studies with prior probabilities on the null and alternative hypothesesDonglin Zeng, Zhiying Pan, D Y Lin
Therapeutic Innovation & Regulatory Science|April 2, 2021
Design and Analysis of a Biosimilar Bridging Study with a Prediction Interval-Based Consistency TestZhiying Pan, Wenying Huang, Jianhong Pan, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2017
A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult menRichard Markus, Vincent Chow, Zhiying Pan, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2018
A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjectsVladimir Hanes, Vincent Chow, Zhiying Pan, et al.
Cancer Chemotherapy and Pharmacology|November 22, 2017
Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult menRichard Markus, Vincent Chow, Zhiying Pan, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Biometrics|January 13, 2006
Goodness-of-fit methods for generalized linear mixed modelsZhiying Pan, D Y Lin
Journal of Glaucoma|May 24, 2011
Longitudinal changes in anterior chamber configuration in eyes with open-angle glaucoma and associated factorsZhiying Pan, Toshie Furuya, Kenji Kashiwagi
Journal of Biopharmaceutical Statistics|June 9, 2022
A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical dataWen Zhang, Zhiying Pan, Ying Yuan
Contemporary Clinical Trials|September 10, 2021
Elastic meta-analytic-predictive prior for dynamically borrowing information from historical data with application to biosimilar clinical trialsWen Zhang, Zhiying Pan, Ying Yuan
Current Eye Research|February 17, 2012
Role of retinal glial cell glutamate transporters in retinal ganglion cell survival following stimulation of NMDA receptorToshie Furuya, Zhiying Pan, Kenji Kashiwagi
Biometrics|November 15, 2019
Design and analysis of bridging studies with prior probabilities on the null and alternative hypothesesDonglin Zeng, Zhiying Pan, D Y Lin
Therapeutic Innovation & Regulatory Science|April 2, 2021
Design and Analysis of a Biosimilar Bridging Study with a Prediction Interval-Based Consistency TestZhiying Pan, Wenying Huang, Jianhong Pan, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2017
A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult menRichard Markus, Vincent Chow, Zhiying Pan, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2018
A randomized, single-blind, single-dose study to assess the pharmacokinetic equivalence of the biosimilar ABP 215 and bevacizumab in healthy Japanese male subjectsVladimir Hanes, Vincent Chow, Zhiying Pan, et al.
Cancer Chemotherapy and Pharmacology|November 22, 2017
Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult menRichard Markus, Vincent Chow, Zhiying Pan, et al.
Pageof 5